CYSTATIN-C AS A MARKER FOR RENAL IMPAIRMENT IN PREECLAMPSIA

被引:0
|
作者
Niraula, A. [1 ]
Lamsal, M. [2 ]
Baral, N. [2 ]
Majhi, S. [2 ]
Khan, S. [2 ]
Basnet, P. [3 ]
机构
[1] BPKIHS, Dept Biochem, Dharan, Nepal
[2] Dept Biochem, Dharan, Nepal
[3] Dept Obstet & Gynecol, Dharan, Nepal
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:63 / 63
页数:1
相关论文
共 50 条
  • [1] Is serum cystatin-C a suitable marker of renal function in children?
    Zaffanello, Marco
    Franchini, Massimo
    Fanos, Vassilios
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2007, 37 (03): : 233 - 240
  • [2] Cystatin-C and acute coronary syndromes: the best renal risk marker?
    Caetano, Ana Francisca
    Almeida, Ines
    Seca, Luis
    Silva, Joana
    Botelho, Ana
    Mota, Paula
    Marques, Antonio Leitao
    CIRCULATION, 2012, 125 (19) : E786 - E786
  • [3] CYSTATIN-C AS A MEASURE OF RENAL FUNCTION
    Bhusari, Sadanand M.
    Madraki, Raveendra
    Divate, S.
    Halankar, A. R.
    Almeida, A. F.
    NEPHROLOGY, 2005, 10 : A142 - A143
  • [4] CYSTATIN-C - A NOVEL MARKER OF RENAL DAMAGE IN OBSTRUCTIVE NEPHROPATHY AND RENAL-TRANSPLANT MONITORING
    NEWMAN, DJ
    THAKKAR, H
    KARIM, O
    KITIYAKARA, C
    ALTMANN, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 397 - 397
  • [5] Is serum cystatin-C a reliable marker for metabolic syndrome?
    Servais, Aude
    Giral, Philippe
    Bernard, Maguy
    Bruckert, Eric
    Deray, Gilbert
    Bagnis, Corinne Isnard
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (05): : 426 - 432
  • [6] Cystatin-C: An early marker of renal impairment and an independent predictive factor for survival in multiple myeloma. Reduction post bortezomib
    Terpos, E.
    Katodritou, E.
    Tsiftsakis, E.
    Verrou, E.
    Christoulas, D.
    Anagnostopoulos, A.
    Banti, A.
    Pouli, A.
    Tsionos, K.
    Dimopoulos, M. A.
    Zervas, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 118 - 118
  • [7] Cystatin-C is a sensitive marker of renal impairment with an independent predictive value for survival in multiple myeloma; Reduction post bortezomib monotherapy
    Terpos, Evangelos
    Katodritou, Eirini
    Tsiftsakis, Evangelos
    Kastritis, Efstathios
    Pouli, Anastasia
    Christoulas, Dimitrios
    Michali, Evridiki
    Verrou, Evgenia
    Banti, Anastasia
    Tsionos, Konstantinos
    Dimopoulos, Meletios A.
    Zervas, Konstantmos
    BLOOD, 2007, 110 (11) : 444A - 444A
  • [8] Cystatin-C a sensitive diagnostic marker for evaluation of the renal function in patients with cisplatin based chemotherapy
    Boelke, E.
    Matuschek, C.
    Peiper, M.
    Giro, C.
    Pelzer, M.
    Budach, W.
    Gripp, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] SERUM CYSTATIN-C - A REPLACEMENT FOR CREATININE AS A BIOCHEMICAL MARKER OF GFR
    NEWMAN, DJ
    THAKKAR, H
    EDWARDS, RG
    WILKIE, M
    WHITE, T
    GRUBB, AO
    PRICE, CP
    KIDNEY INTERNATIONAL, 1994, : S20 - S21
  • [10] Cystatin-C and acute coronary syndromes: a better risk marker?
    Simoes Marques Assuncao Caetano, A. F.
    Barra, S.
    Gomes, P.
    Faustino, C.
    Botelho, A.
    Mota, P.
    Leitao Marques, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 650 - 650